GLP-1 too expensive?

Here's what you can actually pay.

We track active manufacturer savings cards and copay programs for every major GLP-1 medication. Updated May 2026.

Important: Drug pricing and savings programs change frequently. Verify current eligibility directly with the manufacturer before applying. This content is not medical or financial advice.

Active Savings Programs

All five programs verified May 2026. Click any card for full eligibility details and step-by-step application instructions.

Wegovy (semaglutide)

Novo Nordisk

Active
Savings:Up to $500/month
Max monthly cost:$0 for eligible patients
Who qualifies:Commercially insured, income limits apply

Verified: May 2026

Ozempic (semaglutide)

Novo Nordisk

Active
Savings:Up to $150/month
Max monthly cost:$25 per 1-, 2-, or 3-month prescription
Who qualifies:Commercially insured, not for Medicare/Medicaid

Verified: May 2026

Zepbound (tirzepatide)

Eli Lilly

Active
Savings:Up to $573/month
Max monthly cost:$25/month with card
Who qualifies:Commercially insured, not for government programs

Verified: May 2026

Mounjaro (tirzepatide)

Eli Lilly

Active
Savings:Up to $573/month
Max monthly cost:$25/month with card
Who qualifies:Commercially insured, not for government programs

Verified: May 2026

Saxenda (liraglutide)

Novo Nordisk

Active
Savings:Up to $200/month
Max monthly cost:Varies by plan
Who qualifies:Commercially insured adults

Verified: May 2026

No insurance? You still have options.

Telehealth programs, patient assistance plans, and compounded alternatives can bring monthly costs under $200 for many patients.

See uninsured strategies

Drug Pricing Guides

Important: Drug pricing and savings programs change frequently. Verify current eligibility directly with the manufacturer before applying. This content is not medical or financial advice.